AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-118893870/merck-kgaa-returns-theratope.html" title="Facts and information about Merck, KGaA, returns Theratope rights.">Merck, KGaA, returns Theratope rights.</a>
Close
Set up an RSS feed that alerts you when new articles from Vaccine Weekly are available.
Frequently asked questions about RSS feeds
Merck, KGaA, returns Theratope rights.
2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM) and Merck, KGaA, of Darmstadt, Germany, announced that development and commercialization rights to the therapeutic cancer vaccine, Theratope, will be returned to Biomira.
The decision does not impact Merck's and Biomira's on-going collaboration to develop BLP25 Liposome Vaccine (L-BLP25) that the companies are investigating for non-small cell lung cancer.
Merck, KGaA, decided not to pursue Theratope, which is being developed for the treatment of metastatic breast cancer, because additional trials are likely to be required to support registration ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- A Report Covering Merck KGaA, Including Their Deals, Financial Information, and...
- Press release article from: Business Wire November 11, 2005 700+ words
...reports/c26873 ) has announced the addition of Merck KGaA Deals Briefing to their offering. Description Merck KGaA Deals briefing provides an in-depth view of the 83 deals made by Merck KGaA and its subsidiaries with 116 partnering companies between...
- HUMAN GENOME SCIENCES, SMITHKLINE BEECHAM, AND MERCK KGaA SIGN GENOMICS...
- Press release article from: PR Newswire July 16, 1996 700+ words
...SmithKline Beecham (SB), and Merck KGaA of Darmstadt, Germany today announced...agreement for a collaboration in which Merck KGaA would pursue the discovery and development...2001. Through this collaboration, Merck KGaA joins HGS, SB, Takeda Chemical Industries...
- ImClone Systems and Merck KGaA Sign Development and Commercialization Agreement...
- Press release article from: Business Wire December 15, 1998 700+ words
...Incorporated (NASDAQ: IMCL) and Merck KGaA (DAX: MRX GR) announced today that they...Under the terms of the agreement, Merck KGaA receives the exclusive license to develop...the commercial production of C225. Merck KGaA will fund clinical development outside...
- Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra...
- Press release article from: Business Wire October 17, 2001 700+ words
...orders in favor of the plaintiffs and against Merck KGaA on the final post-judgment motions in the case...LifeSciences I Ltd. and The Burnham Institute v. Merck KGaA. The Court denied Merck KGaA's motions for judgment as a matter of law and for...
- Equant Provides Business-Critical Network Services to Merck KGaA and Other...
- Press release article from: Business Wire January 21, 2003 700+ words
...Access Services to More Than 100 Merck KGaA Locations Worldwide Equant (NYSE: ENT...dollar contract extension with Merck KGaA to continue managing and monitoring the...through 2004. Equant has worked with Merck KGaA since 1999. Currently more than 100 of...
- Merck KGaA and ImClone Systems Correct Statements Made Concerning ERBITUX -TM-;...
- Press release article from: Business Wire May 16, 2002 700+ words
...2002 In response to earlier reports, Merck KGaA and ImClone Systems today reiterated Merck KGaA's commitment to sharing clinical data with...for ERBITUX, both ImClone Systems and Merck KGaA are contractually obligated to share all clinical...
- Merck KGaA and ImClone Systems Correct Statements Made Concerning Erbitux(TM);...
- Press release article from: PR Newswire May 17, 2002 700+ words
...YORK -- In response to earlier reports, Merck KGaA and ImClone Systems today reiterated Merck KGaA's commitment to sharing clinical data with...for Erbitux, both ImClone Systems and Merck KGaA are contractually obligated to share all clinical...
- Merck KGaA Selects MDL's ISIS/Direct as the New Foundation of Their Research...
- Press release article from: Business Wire March 4, 2002 700+ words
...and academia, announced today that Merck KGaA has selected MDL's ISIS/Direct data...will enable software developers at Merck KGaA to design and deploy sophisticated systems...addition to managing reactions, Merck KGaA scientists using ISIS/Direct will be...
- Merck KGaA to announce European colorectal cancer study data of Erbitux...
- Press release article from: PR Newswire May 27, 2003 700+ words
...for approval in Europe this summer Merck KGaA of Darmstadt, Germany, will unveil some...oncology drugs in the pipeline of Merck KGaA and its U.S. subsidiary, EMD Pharmaceuticals, Inc. Merck KGaA plans to submit an application for approval...
- Merck KGaA to Announce European Colorectal Cancer Study Data of Erbitux...
- Press release article from: PR Newswire May 27, 2003 700+ words
...Germany, May 27 /PRNewswire/ -- Merck KGaA of Darmstadt, Germany, will unveil some...oncology drugs in the pipeline of Merck KGaA and its U.S. subsidiary, EMD Pharmaceuticals, Inc. Merck KGaA plans to submit an application for approval...
Source: HighBeam Research, Merck, KGaA, returns Theratope rights.